|
[1]
|
Adam, S., McIntyre, H.D., Tsoi, K.Y., Kapur, A., Ma, R.C., Dias, S., et al. (2023) Pregnancy as an Opportunity to Prevent Type 2 Diabetes Mellitus: FIGO Best Practice Advice. International Journal of Gynecology & Obstetrics, 160, 56-67. https://doi.org/10.1002/ijgo.14537
|
|
[2]
|
王晨, 杨慧霞. 国际妇产科联盟最佳实践建议解读——妊娠为2型糖尿病的预防提供了机会[J]. 实用妇产科杂志, 2023, 39(5): 354-356.
|
|
[3]
|
夏亮. 小心妊娠期糖尿病[J]. 科学生活, 2026(1): 28-29.
|
|
[4]
|
华医学会妇产科学分会产科学组, 中华医学会围产医学分会妊娠合并糖尿病协作组. 妊娠合并糖尿病诊治指南(2014) [J]. 中国实用乡村医生杂志, 2017, 24(8): 45-52.
|
|
[5]
|
中华医学会糖尿病学分会. 中国糖尿病防治指南(2024版) [J]. 中华糖尿病杂志, 2025, 17(1): 16-139.
|
|
[6]
|
孙健斌, 袁宁, 赵心, 等. 妊娠期显性糖尿病与不良妊娠结局的研究[J]. 实用妇产科杂志, 2024, 40(10): 828-832.
|
|
[7]
|
邢堃, 张同庆, 康程. 妊娠糖尿病患者血清miR-130b3p、miR-181a-5p表达与妊娠结局的关系[J]. 国际检验医学杂志, 2024, 45(13): 1627-1631.
|
|
[8]
|
周英凤, 邢年路, 李丽, 等. 妊娠期糖尿病非药物管理患者指南的解读[J]. 护士进修杂志, 2024, 39(17): 1820-1824.
|
|
[9]
|
陈恒颖, 郑宝华, 蒋燕芬, 等. 孕前超重肥胖合并妊娠糖尿病对子代0-1岁BMIZ生长轨迹的影响[J]. 华中科技大学学报(医学版), 2025, 54(5): 679-685.
|
|
[10]
|
王颖, 白桦, 张凤芝, 等. 妊娠期糖尿病高危因素及预防措施研究进展[J]. 现代预防医学, 2020, 47(1): 156-159.
|
|
[11]
|
Najafi, F., Hasani, J., Izadi, N., Hashemi-Nazari, S., Namvar, Z., Shamsi, H., et al. (2021) Risk of Gestational Diabetes Mellitus by Pre-Pregnancy Body Mass Index: A Systematic Review and Meta-Analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15, Article ID: 102181. https://doi.org/10.1016/j.dsx.2021.06.018
|
|
[12]
|
Lewandowska, M., Więckowska, B. and Sajdak, S. (2020) Pre-Pregnancy Obesity, Excessive Gestational Weight Gain, and the Risk of Pregnancy-Induced Hypertension and Gestational Diabetes Mellitus. Journal of Clinical Medicine, 9, Article No. 1980. https://doi.org/10.3390/jcm9061980
|
|
[13]
|
张佳, 王军, 徐艳. 宿迁地区高龄产妇孕前体质指数尧孕期增重情况及血红蛋白水平对小于胎龄儿出生状况的影响研究[J]. 中国医学前沿杂志(电子版), 2018, 10(11): 28-31.
|
|
[14]
|
胡晓莉. 高龄孕妇孕前体质量指数联合孕期体重增加情况对妊娠结局的预测价值[J]. 医学信息, 2024, 37(24): 66-68, 80.
|
|
[15]
|
Alejandro, E.U., Mamerto, T.P., Chung, G., Villavieja, A., Gaus, N.L., Morgan, E., et al. (2020) Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes. International Journal of Molecular Sciences, 21, Article No. 5003. https://doi.org/10.3390/ijms21145003
|
|
[16]
|
张承焕, 韦喜利, 钟海. 糖耐量试验联合糖化血红蛋白、空腹胰岛素检测对多囊卵巢综合征孕妇在妊娠糖尿病诊断中的应用价值[J]. 贵州医药, 2025, 49(5): 770-772.
|
|
[17]
|
Mills, G., Badeghiesh, A., Suarthana, E., Baghlaf, H. and Dahan, M.H. (2020) Polycystic Ovary Syndrome as an Independent Risk Factor for Gestational Diabetes and Hypertensive Disorders of Pregnancy: A Population-Based Study on 9.1 Million Pregnancies. Human Reproduction, 35, 1666-1674. https://doi.org/10.1093/humrep/deaa099
|
|
[18]
|
Foroozanfard, F., Asemi, Z., Bazarganipour, F., Taghavi, S.A., Allan, H. and Aramesh, S. (2020) Comparing Pregnancy, Childbirth, and Neonatal Outcomes in Women with Different Phenotypes of Polycystic Ovary Syndrome and Healthy Women: A Prospective Cohort Study. Gynecological Endocrinology, 36, 61-65. https://doi.org/10.1080/09513590.2019.1631278
|
|
[19]
|
卢永军, 赵志玲, 焦钰洁, 等. 多囊卵巢综合征337例发生妊娠期糖尿病的高危因素分析[J]. 安徽医药, 2023, 27(6): 1188-1191.
|
|
[20]
|
Kim, C., Liu, T., Valdez, R. and Beckles, G.L. (2009) Does Frank Diabetes in First-Degree Relatives of a Pregnant Woman Affect the Likelihood of Her Developing Gestational Diabetes Mellitus or Non-Gestational Diabetes? American Journal of Obstetrics and Gynecology, 201, 576.e1-576.e6. https://doi.org/10.1016/j.ajog.2009.06.069
|
|
[21]
|
Dziedziejko, V., Safranow, K., Tarnowski, M. and Pawlik, A. (2019) Common Type 2 Diabetes Genetic Risk Variants Improve the Prediction of Gestational Diabetes. Hormone and Metabolic Research, 51, 655-660. https://doi.org/10.1055/a-0945-0328
|
|
[22]
|
胡路遥, 汤益波, 梁朝霞. 妊娠期糖尿病免疫相关发病机制的研究进展[J]. 中华预防医学杂志, 2024, 58(3): 394-399.
|
|
[23]
|
贾佳利, 王锡梅. 妊娠期糖尿病患者血脂水平和胰岛素抵抗的相关性分析[J]. 贵州医药, 2023, 47(3): 392-393.
|
|
[24]
|
Li, H., Chai, Y., Guo, H.W., et al. (2024) Gestational Diabetes Mellitus Combined with Fulminant Type 1 Diabetes Mellitus, Four Cases of Double Diabetes: A Case Report. World Journal of Clinical Cases, 12, 787-794.
|
|
[25]
|
许宏娇. 胰岛素泵联合膳食指导对妊娠期糖尿病患者的效果[J]. 中外医学研究, 2026, 24(1): 71-73.
|
|
[26]
|
Plows, J.F., Stanley, J.L., Baker, P.N., Reynolds, C.M. and Vickers, M.H. (2018) The Pathophysiology of Gestational Diabetes Mellitus. International Journal of Molecular Sciences, 19, Article No. 3342. https://doi.org/10.3390/ijms19113342
|
|
[27]
|
辛雅萍, 阮梦梦, 马晓静, 等. 血清脂肪因子CTRP7与妊娠期糖尿病的关系[J]. 中国生育健康杂志, 2026, 37(1): 46-49.
|
|
[28]
|
杨慧霞. 妊娠期糖尿病: 胰岛β细胞功能再评价[J]. 药品评价, 2017, 14(21): 5-6+14.
|
|
[29]
|
李阳, 蒋玉芬, 李奕. 妊娠期糖尿病患者发病的危险因素及炎性应激状态分析[J]. 实用临床医药杂志, 2025, 29(4): 64-68.
|
|
[30]
|
杨蕊华, 袁仙仙, 李光辉. 炎症相关指标与妊娠期糖尿病关系的研究进展[J]. 中华围产医学杂志, 2023, 26(4): 344-349.
|
|
[31]
|
郑玉红, 钟宏文, 古菁华, 等. 妊娠期糖尿病患者外周血炎症指标与胰岛素抵抗相关性研究[J]. 临床医药实践, 2025, 34(2): 126-130.
|
|
[32]
|
关娜, 苏妍. 参麦地黄汤联合胰岛素治疗气阴两虚型妊娠期糖尿病的效果及对代谢指标和炎症因子水平的影响[J]. 天津中医药, 2025, 42(3): 297-300.
|
|
[33]
|
李稳安, 付胜蓝, 侯志金, 等. 肿瘤坏死因子-α及其抑制剂在生殖领域的研究进展[J]. 国际生殖健康/计划生育杂志, 2025, 44(3): 259-264.
|
|
[34]
|
乌日汉, 孟海霞. 血清肿瘤坏死因子与妊娠相关疾病的研究[J]. 临床医学进展, 2024, 14(1): 839-845.
|
|
[35]
|
Mavreli, D., Evangelinakis, N., Papantoniou, N. and Kolialexi, A. (2020) Quantitative Comparative Proteomics Reveals Candidate Biomarkers for the Early Prediction of Gestational Diabetes Mellitus: A Preliminary Study. In Vivo, 34, 517-525. https://doi.org/10.21873/invivo.11803
|
|
[36]
|
Francis, E.C., Li, M., Hinkle, S.N., Cao, Y., Chen, J., Wu, J., et al. (2020) Adipokines in Early and Mid-Pregnancy and Subsequent Risk of Gestational Diabetes: A Longitudinal Study in a Multiracial Cohort. BMJ Open Diabetes Research & Care, 8, e001333. https://doi.org/10.1136/bmjdrc-2020-001333
|
|
[37]
|
Wander, P.L., Christophi, C.A., Araneta, M.R.G., Boyko, E.J., Enquobahrie, D.A., Dabelea, D., et al. (2022) Adiposity, Related Biomarkers, and Type 2 Diabetes after Gestational Diabetes: The Diabetes Prevention Program. Obesity, 30, 221-228. https://doi.org/10.1002/oby.23291
|
|
[38]
|
白晶, 秦一川, 刘瑜, 等. 脂联素在妊娠期糖尿病中的临床应用及早期风险模型的建立[J]. 首都医科大学学报, 2025, 46(3): 567-575.
|
|
[39]
|
陆小莉, 林筱君, 章馨, 等. 妊娠期糖尿病患者抗阻训练血清脂联素及妊娠结局相关研究[J]. 中华保健医学杂志, 2024, 26(6): 869-872.
|
|
[40]
|
沈昊, 吴宇杰, 陈永仪. 外周血瘦素、摄食抑制因子、脂肪因子趋化素对妊娠期糖尿病母婴结局的预测分析[J]. 四川解剖学杂志, 2023, 31(3): 70-73.
|
|
[41]
|
贾忠兰, 卢新, 王雅杰, 等. 瘦素、脂联素、抵抗素、内肥素与妊娠糖尿病胰岛素抵抗的相关性研究[J]. 中国免疫学杂志, 2008, 24(12): 1133-1135.
|
|
[42]
|
Lobo, T.F., Torloni, M.R., Mattar, R., Nakamura, M.U., Alexandre, S.M. and Daher, S. (2019) Adipokine Levels in Overweight Women with Early-Onset Gestational Diabetes Mellitus. Journal of Endocrinological Investigation, 42, 149-156. https://doi.org/10.1007/s40618-018-0894-0
|
|
[43]
|
韩静. 盐酸二甲双胍与门冬胰岛素联合治疗妊娠期糖尿病的临床效果及母婴结局影响研究[J]. 糖尿病天地, 2024, 21(2): 22-23.
|
|
[44]
|
段希芳. 地特胰岛素联合门冬胰岛素治疗妊娠糖尿病的临床效果研究[J]. 中外医药研究, 2025, 4(6): 15-17.
|
|
[45]
|
赵田园, 樊高省. 地特胰岛素联合门冬胰岛素治疗对妊娠期糖尿病患者的临床效果[J]. 航空航天医学杂志, 2024, 35(11): 1333-1335.
|
|
[46]
|
俞秀荣, 陈惠平. 地特胰岛素联合门冬胰岛素治疗妊娠糖尿病患者的效果及对母婴结局的影响[J]. 北方药学, 2024, 21(7): 157-159.
|
|
[47]
|
赵异葩, 周丽霞. 二甲双胍联合胰岛素治疗妊娠期糖尿病的效果[J]. 中国药物滥用防治杂志, 2025, 31(4): 706-707+716.
|
|
[48]
|
王立娟. 二甲双胍、门冬胰岛素联合治疗方案在妊娠期糖尿病产妇中应用后对妊娠结局的影响[J]. 糖尿病新世界, 2021, 24(7): 98-102.
|
|
[49]
|
潘敏. 二甲双胍联合黄芪四君子汤治疗妊娠期糖尿病的疗效及对妊娠结局、糖化血红蛋白水平的影响分析[J]. 中国实用医药, 2025, 20(5): 117-120.
|